166 related articles for article (PubMed ID: 7040994)
1. Application of tube LAI assay in larynx cancer patients.
Hasek M; Holán V; Síbl O; Kousalová M
Neoplasma; 1981; 28(6):685-8. PubMed ID: 7040994
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
Holán V; Síbl O; Hasek M
Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
[TBL] [Abstract][Full Text] [Related]
3. Tube LAI assay in diagnosis and monitoring of a cancer disease.
Hasek M; Holán V; Kousalová M
Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
[TBL] [Abstract][Full Text] [Related]
5. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
6. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
7. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
8. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
Horváth M; Tóth L; Tóth J; Fekete B
Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
[TBL] [Abstract][Full Text] [Related]
9. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
[TBL] [Abstract][Full Text] [Related]
12. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):607-19. PubMed ID: 3526756
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
15. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
Tannenbaum H; Wild J
Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
[TBL] [Abstract][Full Text] [Related]
16. The leukocyte adherence inhibition test (LAI) in preoperative diagnosis of epithelial ovarian cancer.
Dgani R; Shani A; Elchalal U; Harpaz N; Bentwich Z; Fink A
Gynecol Oncol; 1993 Jun; 49(3):349-53. PubMed ID: 8314537
[TBL] [Abstract][Full Text] [Related]
17. Comparison of LAI reactivity in B 77 tumor bearing rats between, before and after surgical removal of tumors.
Pham Manh Hung ; Kalafut F; Novotná L
Neoplasma; 1980; 27(4):367-71. PubMed ID: 7005698
[TBL] [Abstract][Full Text] [Related]
18. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
19. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
[TBL] [Abstract][Full Text] [Related]
20. Immunological response of patients with tumors of the urogenital tract: a follow-up of cell-mediated antitumor immunity by the LAI test.
Holán V; Heyberger K; Bubeník J; Hasek M; Kanka J; Laurová L
Neoplasma; 1977; 24(1):71-9. PubMed ID: 320490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
